Pressreleases

New Promega Luciferase is Smaller, Brighter, and More Versatile

Promega Corporation announces the launch of a novel luciferase that is smaller, brighter, and more versatile than any current bioluminescent enzyme. These attributes of the NanoLuc™ Luciferase provide new capabilities in reporter assays with potential in biologically complex applications that require greater sensitivity.

Promega Extends Range of ReliaPrep MiniPrep Systems

Promega Corporation announced today that it has launched the ReliaPrep™ 96 gDNA MiniPrep HT System to complement the recently released ReliaPrep RNA Cell MiniPrep System, for the extraction and isolation of gDNA and RNA respectively.

Marina Biotech and Girindus Group Announce Strategic Alliance

Marina Biotech, Inc. (OTCQX:MRNA), a leading nucleic acid-based drug discovery and development company and Girindus Group today announced that they have entered into a strategic alliance where Girindus will have exclusive rights to develop, supply and commercialize certain oligonucleotide constructs using Marina’s Conformationally Restricted Nucleotide (CRN) chemistry and in return, Marina will receive royalties from the sale of CRN-based oligonucleotide reagents as well as a robust supply of cGMP material for Marina and its partners’ pre-clinical, clinical and commercialization needs.

SHL’s auto injector talk sparks interest at recent Japan PDA

SHL recently spoke and exhibited at the Japan PDA’s Prefilled Syringe Seminar in Tokyo from May 22nd-23rd and received excellent feedback from many of the conference attendees.

Rhenovia Pharma opens first US office

Expands activities to the Greater Boston Area Deployment will widen use of biosimulation technology.

Rhenovia launches drug discovery programs in rare, orphan and neglected neurodegenerative diseases

Neurological specialist will carry out research based on its unique biosimulation platforms.

Rhenovia files patents for new treatment of Huntington’s disease based on its innovative Biosimulation Platform

Rhenovia Pharma, a leading biotech company in biosimulation applied to the discovery of new medications to treat neurodegenerative, neurological and

Diapharm to raise international awareness of country-specific traditional medicines

Pharmaceutical service provider Diapharm is planning to raise the profile of traditional herbal medicinal products which have to date only been used in individual EU countries.

Pharmaceutical service provider expands its borders: Diapharm opens office in Austria

Pharmaceutical service provider Diapharm is continuing its international expansion. In October 2011, Diapharm Austria GmbH opens for business in Vienna.